Third-Generation Autologous Chondrocyte Implantation (Cells Cultured Within Collagen Membrane) Is Superior to Microfracture for Focal Chondral Defects of the Knee Joint: Systematic Review and Meta-analysis

医学 自体软骨细胞移植 随机对照试验 骨关节炎 科克伦图书馆 外科 磁共振成像 软骨 可视模拟标度 关节软骨 放射科 病理 解剖 替代医学
作者
Jaydeep Dhillon,Alexander P. Decilveo,Matthew J. Kraeutler,John W. Belk,Patrick C. McCulloch,Anthony J. Scillia
出处
期刊:Arthroscopy [Elsevier]
卷期号:38 (8): 2579-2586 被引量:17
标识
DOI:10.1016/j.arthro.2022.02.011
摘要

Purpose To systematically review randomized controlled trials to compare clinical outcomes of microfracture (MFx) versus third-generation autologous chondrocyte implantation (ACI) for the treatment of focal chondral defects (FCDs) of the knee joint. Methods A systematic review was performed by searching PubMed, Cochrane Library, and EMBASE to locate randomized controlled trials comparing minimum 2-year clinical outcomes of patients undergoing MFx versus third-generation ACI for FCDs of the knee joint. The search terms used were: “knee” AND “microfracture” AND “autologous chondrocyte” AND “randomized.” Patients were evaluated based on treatment failure rates, magnetic resonance imaging, International Cartilage Repair Society scores, and patient-reported outcome scores (Lysholm, Tegner, Knee Injury and Osteoarthritis Outcome Score, modified Cincinnati Knee Rating System, 12-item Short Form Health Survey Physical and Mental, and the EuroQol 5 Dimensions Visual Analog Scale score). Results Six studies (5 Level I, 1 Level II) met inclusion criteria, including a total of 238 patients undergoing MFx and 274 undergoing ACI. Two studies had an overlapping cohort of patients and therefore the study with longer follow-up was used in all analyses. The average follow-up among patients ranged from 2.0 years to 6.0 years. Average lesion size ranged from 1.8 cm2 to 5.0 cm2. Treatment failure ranged from 0% to 1.8% in the ACI group and 2.5% to 8.3% in the MFx group. In 4 studies, ACI patients demonstrated significantly greater improvement in multiple Knee Injury and Osteoarthritis Outcome Score subscores compared with MFx. In 2 studies, patients who received ACI demonstrated significantly greater improvement in the Tegner score compared to MFx, and 1 study showed significantly greater improvement in the Lysholm and ICRS scores for ACI compared with MFx. Conclusions At short-term follow-up, third-generation ACI demonstrates a lower failure rate and greater improvement in patient-reported outcomes compared with MFx for FCDs of the knee joint. Level of Evidence II, systematic review of Levels I-II studies. To systematically review randomized controlled trials to compare clinical outcomes of microfracture (MFx) versus third-generation autologous chondrocyte implantation (ACI) for the treatment of focal chondral defects (FCDs) of the knee joint. A systematic review was performed by searching PubMed, Cochrane Library, and EMBASE to locate randomized controlled trials comparing minimum 2-year clinical outcomes of patients undergoing MFx versus third-generation ACI for FCDs of the knee joint. The search terms used were: “knee” AND “microfracture” AND “autologous chondrocyte” AND “randomized.” Patients were evaluated based on treatment failure rates, magnetic resonance imaging, International Cartilage Repair Society scores, and patient-reported outcome scores (Lysholm, Tegner, Knee Injury and Osteoarthritis Outcome Score, modified Cincinnati Knee Rating System, 12-item Short Form Health Survey Physical and Mental, and the EuroQol 5 Dimensions Visual Analog Scale score). Six studies (5 Level I, 1 Level II) met inclusion criteria, including a total of 238 patients undergoing MFx and 274 undergoing ACI. Two studies had an overlapping cohort of patients and therefore the study with longer follow-up was used in all analyses. The average follow-up among patients ranged from 2.0 years to 6.0 years. Average lesion size ranged from 1.8 cm2 to 5.0 cm2. Treatment failure ranged from 0% to 1.8% in the ACI group and 2.5% to 8.3% in the MFx group. In 4 studies, ACI patients demonstrated significantly greater improvement in multiple Knee Injury and Osteoarthritis Outcome Score subscores compared with MFx. In 2 studies, patients who received ACI demonstrated significantly greater improvement in the Tegner score compared to MFx, and 1 study showed significantly greater improvement in the Lysholm and ICRS scores for ACI compared with MFx. At short-term follow-up, third-generation ACI demonstrates a lower failure rate and greater improvement in patient-reported outcomes compared with MFx for FCDs of the knee joint.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大力的寻琴完成签到 ,获得积分10
刚刚
黑摄会阿Fay完成签到,获得积分10
刚刚
mescal完成签到,获得积分10
1秒前
lezbj99发布了新的文献求助10
1秒前
ding应助欣喜乐天采纳,获得10
1秒前
2秒前
连糜完成签到 ,获得积分10
2秒前
stop here完成签到,获得积分10
2秒前
靓丽行天完成签到,获得积分10
2秒前
包容鸭子发布了新的文献求助10
4秒前
bkagyin应助一文字豪树采纳,获得10
4秒前
5秒前
非常完成签到,获得积分10
5秒前
Sheart发布了新的文献求助10
5秒前
123完成签到,获得积分10
6秒前
风趣世开完成签到 ,获得积分10
6秒前
陶醉的又夏完成签到 ,获得积分10
6秒前
在水一方应助权雨灵采纳,获得10
7秒前
丹丹子完成签到 ,获得积分10
8秒前
我是老大应助zty采纳,获得10
8秒前
666完成签到 ,获得积分10
9秒前
体贴薯片完成签到,获得积分10
10秒前
xiao完成签到,获得积分10
10秒前
青田101完成签到,获得积分10
11秒前
合适的寄灵完成签到 ,获得积分10
11秒前
天天快乐应助化工人采纳,获得10
11秒前
12秒前
12秒前
shashouzongshuai完成签到,获得积分10
12秒前
xiaowang完成签到,获得积分10
13秒前
marchon完成签到 ,获得积分10
13秒前
大模型应助犹豫小海豚采纳,获得10
13秒前
余琳完成签到,获得积分10
14秒前
11号迪西馅饼完成签到,获得积分10
14秒前
沉静寒云完成签到 ,获得积分10
15秒前
Pride完成签到 ,获得积分10
15秒前
flow完成签到,获得积分10
15秒前
15秒前
123完成签到,获得积分10
16秒前
喜来乐完成签到,获得积分10
17秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
叶剑英与华南分局档案史料 500
Foreign Policy of the French Second Empire: A Bibliography 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3147001
求助须知:如何正确求助?哪些是违规求助? 2798279
关于积分的说明 7827502
捐赠科研通 2454919
什么是DOI,文献DOI怎么找? 1306492
科研通“疑难数据库(出版商)”最低求助积分说明 627808
版权声明 601565